Revision: April 22, 2026, 11:34 a.m.
Senate Health and Human Services
April 22, 2026
2026-1623s
05/09
Amendment to HB 1772-FN-A
Amend the bill by replacing section 1 with the following:
1 New Section; Ibogaine; Administered Under FDA-approved Research Protocol. Amend RSA 329 by inserting after section RSA 329:1-h the following new section:
329:1-i Ibogaine; Administered Under FDA-approved Research Protocol. To the extent allowable by federal law, licensed physicians or qualified licensed practitioners may administer ibogaine under the framework of an FDA-approved research protocol.
2026-1623s
AMENDED ANALYSIS
This bill permits licensed health care providers to administer ibogaine under the framework of an FDA-approved research protocol.